Jun 10 |
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
|
Jun 10 |
Moderna Combination Shot Outperforms Standalone Flu, Covid-19 Jabs
|
Jun 10 |
Why Moderna Stock Is a No-Brainer Buy Right Now
|
Jun 10 |
Apple, Moderna, Southwest Airlines rise premarket; Tesla falls
|
Jun 8 |
Moderna, Inc.'s (NASDAQ:MRNA) large institutional owners must be happy as stock continues to impress, up 5.9% over the past week
|
Jun 7 |
FDA selects JN.1 variant for next COVID vaccine campaign
|
Jun 7 |
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
|
Jun 7 |
Acadia (ACAD) Up 0.6% Since Last Earnings Report: Can It Continue?
|
Jun 7 |
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
|
Jun 7 |
Moderna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference (Transcript)
|